These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38058357)

  • 1. Blood-based biomarkers in Alzheimer's disease: Future directions for implementation.
    Suridjan I; van der Flier WM; Monsch AU; Burnie N; Baldor R; Sabbagh M; Vilaseca J; Cai D; Carboni M; Lah JJ
    Alzheimers Dement (Amst); 2023; 15(4):e12508. PubMed ID: 38058357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caregivers' attitudes toward blood-based biomarker testing for Alzheimer's disease.
    Bolsewig K; Blok H; Willemse EAJ; Zwaaftink RBMG; Kooistra M; Smets EMA; Teunissen CE; Visser LNC
    Alzheimers Dement (Amst); 2024; 16(1):e12549. PubMed ID: 38371360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease.
    Mielke MM; Anderson M; Ashford JW; Jeromin A; Lin PJ; Rosen A; Tyrone J; Vandevrede L; Willis DR; Hansson O; Khachaturian AS; Schindler SE; Weiss J; Batrla R; Bozeat S; Dwyer JR; Holzapfel D; Jones DR; Murray JF; Partrick KA; Scholler E; Vradenburg G; Young D; Braunstein JB; Burnham SC; de Oliveira FF; Hu YH; Mattke S; Merali Z; Monane M; Sabbagh MN; Shobin E; Weiner M; Udeh-Momoh CT
    Alzheimers Dement; 2024 Nov; 20(11):8216-8224. PubMed ID: 39351838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-based biomarkers for Alzheimer's pathology and the diagnostic process for a disease-modifying treatment: Projecting the impact on the cost and wait times.
    Mattke S; Cho SK; Bittner T; Hlávka J; Hanson M
    Alzheimers Dement (Amst); 2020; 12(1):e12081. PubMed ID: 32832590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease.
    Howe MD; Britton KJ; Joyce HE; Menard W; Emrani S; Kunicki ZJ; Faust MA; Dawson BC; Riddle MC; Huey ED; Janelidze S; Hansson O; Salloway SP
    Alzheimers Res Ther; 2024 Jul; 16(1):154. PubMed ID: 38971815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease.
    Howe MD; Britton KJ; Joyce HE; Menard W; Emrani S; Kunicki ZJ; Faust MA; Dawson BC; Riddle MC; Huey ED; Janelidze S; Hansson O; Salloway SP
    Res Sq; 2024 May; ():. PubMed ID: 38853872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Biomarkers of Amyloid and Tau Pathology in Alzheimer's Disease: An Overview of Tests for Clinical Practice in the United States and Europe.
    Iaccarino L; Burnham SC; Dell'Agnello G; Dowsett SA; Epelbaum S
    J Prev Alzheimers Dis; 2023; 10(3):426-442. PubMed ID: 37357283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New horizons in the diagnosis and management of Alzheimer's Disease in older adults.
    Dolphin H; Dyer AH; Morrison L; Shenkin SD; Welsh T; Kennelly SP
    Age Ageing; 2024 Feb; 53(2):. PubMed ID: 38342754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projected Annual Lecanemab Treatment Eligibility in an Irish Regional Specialist Memory Clinic.
    Connolly E; O'Connor A; Dolphin H; Dyer AH; Fallon A; O'Dowd S; Kennelly SP
    Int J Geriatr Psychiatry; 2024 Oct; 39(10):e6157. PubMed ID: 39384333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of Current Capacity for Diagnosing Alzheimer's Disease in Sweden and the Need to Expand Specialist Numbers.
    Mattke S; Gustavsson A; Jacobs L; Kern S; Palmqvist S; Eriksdotter M; Skoog I; Winblad B; Wimo A; Jönsson L
    J Prev Alzheimers Dis; 2024; 11(1):155-161. PubMed ID: 38230728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential clinical value of plasma biomarkers in Alzheimer's disease.
    Blennow K; Galasko D; Perneczky R; Quevenco FC; van der Flier WM; Akinwonmi A; Carboni M; Jethwa A; Suridjan I; Zetterberg H
    Alzheimers Dement; 2023 Dec; 19(12):5805-5816. PubMed ID: 37694991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of the diagnostic frontiers of Alzheimer's disease and new therapeutic possibilities].
    Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):38-44. PubMed ID: 36412155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention.
    Udeh-Momoh C; Zheng B; Sandebring-Matton A; Novak G; Kivipelto M; Jönsson L; Middleton L
    J Prev Alzheimers Dis; 2022; 9(1):12-21. PubMed ID: 35098969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease.
    Mohs RC; Beauregard D; Dwyer J; Gaudioso J; Bork J; MaGee-Rodgers T; Key MN; Kerwin DR; Hughes L; Cordell CB;
    Alzheimers Dement; 2024 Apr; 20(4):2752-2765. PubMed ID: 38415908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
    Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
    J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's Dementia: The Emerging Role of Positron Emission Tomography.
    Tripathi SM; Murray AD
    Neuroscientist; 2022 Oct; 28(5):507-519. PubMed ID: 33660556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.